In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 77 for your search:
Drug:  anastrozole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5392C00050, SABRE, NCT00082277

2.

Phase: Phase IV
Type: Diagnostic, Supportive care, Treatment
Status: Closed
Age: 40 to 65
Sponsor: Other
Protocol IDs: 2004/949, NCT00111241

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5392NL0002, ARREST, NCT00246961

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5392L00013, 2005-00-5441-19 EUDRACT number, NCT00323479

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5392L00023, NCT00537771

6.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11 SEIN 09, NCT01553903

7.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11SEIN12, NCT01612871

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ROCHE-BO16216, CWRU-030118, GENENTECH-H2223g, ROCHE-1100, ROCHE-B016216F, NCT00022672

9.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000456382, ACOSOG-Z1031, CALGB-ACOSOG-Z1031, SDC1, NCT00265759

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: ZENECA-1033IL/0030, NCI-V96-1049

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: RPCI-DS-97-29, ZENECA-9238IL/0021, NCI-G98-1412

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: CDR0000269549, FRE-FNCLCC-PACS-03/003, EU-20237, NCT00053911

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000334899, S0221, U10CA032102, SWOG-S0221, NCT00070564

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 40 to 70
Sponsor: Other
Protocol IDs: ISRCTN37546358, EU-20226, BIG-5-02, IBCSG-31-03-DCIS, ISRCTN31488319, CRUK-IBIS-II-DCIS, NCT00072462

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000349337, U10CA032102, S0226, CAN-NCIC-MAC7, SWOG-S0226, NCT00075764

16.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 70
Sponsor: Other
Protocol IDs: ISRCTN31488319, EU-20227, EUDRACT-2004-003991-12, CRUK-IBIS-IIB, IBCSG-31-03-PREV, NCT00078832

17.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: Other
Protocol IDs: ALCC 04.02, NCT00122356

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A5991048, NCT00143390

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CDR0000448616, ICR-CTSU-SOFEA, EU-20531, SSA-04Q200635, ISRCTN44195747, MREC-03677, EUDRACT-2004-000093-30, NCT00253422

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 to 65
Sponsor: Other
Protocol IDs: TMH/153/2004, NCT00193778

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: No age specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345D2411, 2005-004263-35, EUDRACT number 2005-004263-35, NCT00248170

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: D6997L00002, 9238SW/0001, FACT, NCT00256698

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: D5392L00016, ABCSG 16, 1033AU/0003, SALSA, NCT00295620

24.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 19 to 59
Sponsor: Other
Protocol IDs: ABCSG-12, CZOL 446 1B 01, Zol-A-01, NCT00295646

25.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: NCI-2009-00707, CDR0000472066, ECOG-PACCT-1, PACCT-1, U10CA180820, U10CA021115, NCT00310180
1     
New Search